Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…
Lamborghini at the forefront of elegance and speed on Lake Como
Rare Lamborghini models featured at the Concorso d’Eleganza Villa d’Este and Fuoriconcorso…
U.S. FDA Approves Liquidias YUTREPIA (treprostinil) Inhalation Powder forPatients with Pulmonary Arterial Hypertension (PAH) andPulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
May 23, 2025 14:28 ET | Source: Liquidia Technologies, Inc. FDA’s approval…
Runwal Realty Adds a New Chapter to Luxury with Runwal Raaya
Built on a prime 4-acre land parcel in the heart of WorliComprises two…
Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
May 22, 2025 17:32 ET | Source: Soleno Therapeutics REDWOOD CITY, Calif.,…
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational…
THE DALMORE UNVEILS COLLABORATION WITH FOSTER + PARTNERS’ BEN DOBBIN ON THE PRESTIGIOUS LUMINARY SERIES AS 2025 EDITION LAUNCHES IN VENICE
GLASGOW, Scotland, May 8, 2025 /PRNewswire/ -- The Dalmore Single Malt Whisky announce…
Ultragenyx to Participate at Bank of Americas 2025 Healthcare Conference
May 07, 2025 17:00 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
Court will not hear cross-claim that challenges the PH-ILD indication in the…